AstraZeneca appoints Ram Mudaliar to head CDI Division in India

INDIA – AstraZeneca India, the services division of AstraZeneca, has announced the appointment of Ram Mudaliar as the India lead of their Clinical Data & Insights (CDI) division.

Prior to his appointment as CDI India Lead, Ram worked for AstraZeneca Canada, where he was in charge of the Lung portfolio and led Oncology data management teams in the North American and European regions.

For a short time, he served as Interim Global Head of Oncology in Data Management.

The establishment of the Clinical Data & Insights (CDI) division in Bengaluru is a critical step toward supporting a growing global portfolio and expanding internal data expertise.

Ram’s appointment comes after the establishment of the CDI India division in October 2021.

Ram will be in charge of establishing and expanding the CDI footprint in India, as well as collaborating with CDI global and local leaders to develop and implement strategic decisions for the India site.

He is also in charge of ensuring local facility planning and coordination, as well as enabling support for the India team, by collaborating with Facilities Management, Human Resources, IT, Compliance, R&D Site Leadership, and other functions as needed.

Commenting on the appointment of Ram Mudaliar, Siva Padmanabhan, Managing Director, AstraZeneca India, said, “Clinical Data & Insights play a very important role in gaining visibility into patient journey and providing actionable insights. The launch of Clinical Data & Insights team in Bengaluru, India, is a critical advancement to support a growing global portfolio, and build on internal data expertise. Mudaliar’s depth of experience in data management, leadership, strategic insights and broad-based expertise will be an accelerator to the growth of the AstraZeneca’s Clinical Data & Insights Division in India.”

On his appointment, Ram Mudaliar, CDI India Lead, AstraZeneca, in part said, “The way in which we manage data is evolving and the CDI division in India will prepare AstraZeneca for managing clinical data at exponential volume, scale and complexity.

Mudaliar has a master’s degree in biotechnology from India’s Mumbai University. His passion has always been data and insights, and he is especially intrigued by the possibilities it opens up for enabling patient-centric solutions.

He is committed to building high-performing teams that are collaborative, diverse, and welcoming. Mudaliar previously worked for Cognizant Technology Solutions, where he was in charge of Clinical Data Management, Statistical Programming, Analysis, and Medical Writing.

He has been with AstraZeneca for over 5 years, serving in a variety of roles across countries and continents in the Clinical Data Management domain.

Liked this article? Sign up to receive our regular email newsletters, focused on Africa and World’s healthcare industry, directly into your inbox. SUBSCRIBE HERE

Newer Post

Thumbnail for AstraZeneca appoints Ram Mudaliar to head CDI Division in India

Max Healthcare, Muthoot Hospitals to jointly run new hospital in Delhi’s suburb

Older Post

Thumbnail for AstraZeneca appoints Ram Mudaliar to head CDI Division in India

Sema4 acquires genetic testing firm GeneDx for US$623M to strengthen genomic platform

Be the first to leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.